Table 1.
Clinicopathological characteristics of the 46 endometrioid endometrial carcinoma (EEC) patients and six controls in the study.
| Characteristics | Patients (%) | Controls (%) | p |
|---|---|---|---|
| Median age (years) | 64 | 39.5 | 0.003 |
| Variation | 42–83 | 35–72 | |
| Hypertension | 0.07 | ||
| Yes | 29 (63.0) | 1 (16.7) | |
| No | 17 (37.0) | 5 (83.3) | |
| Diabetes | 0.57 | ||
| Yes | 9 (19.6) | 0 (0) | |
| No | 37 (80.4) | 6 (100) | |
| Heart diseases | 1.00 | ||
| Yes | 4 (8.7) | 0 (0) | |
| No | 42 (91.3) | 6 (100) | |
| Obesity or Overweight | 0.63 | ||
| Yes | 35 (76.1) | 4 (66.7) | |
| No | 11 (23.9) | 2 (33.3) | |
| Nulliparity | 1.00 | ||
| Yes | 6 (13.0) | 0 (0) | |
| No | 36 (78.3) | 6 (100) | |
| N/A | 4 (8.7) | ||
| Contraceptive use | 0.33 | ||
| Yes | 11 (23.9) | 3 (50) | |
| No | 32 (69.6) | 3 (50) | |
| N/A | 3 (6.5) | - | |
| Exogenous Estrogen Therapy | 0.16 | ||
| Yes | 0 (0.0) | 1 (16.7) | |
| No | 42 (91.3) | 5 (83.3) | |
| N/A | 4 (8.7) | - | |
| Menopause | |||
| Yes | 38 (82.6) | 3 (50.0) | 0.06 |
| No | 6 (13.0) | 3 (50.0) | |
| N/A | 2 (4.4) | - | |
| FIGO Stage | |||
| IA | 10 (21.7) | ||
| IB | 10 (21.7) | ||
| II | 10 (21.7) | ||
| III | 10 (21.7) | ||
| IV | 6 (13.0) | ||
| Histological Grade | |||
| Well differentiated (G1) | 11 (23.9) | ||
| Moderate differentiated (G2) | 22(47.8) | ||
| Poorly differentiated (G3) | 13 (28.3) | ||
| Lymphovascular Infiltration | |||
| Yes | 7 (15.2) | ||
| No | 29 (63.0) | ||
| N/A | 10 (21.8) | - | |
| Myometrial Invasion | |||
| <50% | 22 (47.8) | ||
| ≥50% | 24 (52.2) | ||
| Recurrence | |||
| Yes | 13 (28.3) | ||
| No | 33 (71.7) |
Fisher’s exact test. N/A: Not informed.